Comprehensive Cancer Centre South (IKZ), Eindhoven Cancer Registry, PO Box 231, 5600 AE Eindhoven, the Netherlands.
Breast Cancer Res Treat. 2011 Jul;128(2):517-25. doi: 10.1007/s10549-011-1363-z. Epub 2011 Feb 3.
The associations of socioeconomic status (SES) and participation in the breast cancer screening program, as well as consequences for stage of disease and prognosis were studied in the Netherlands, where no financial barriers for participating or health care use exist. From 1998 to 2005, 1,067,952 invitations for biennial mammography were sent to women aged 50-75 in the region covered by the Eindhoven Cancer Registry. Screening attendance rates according to SES were calculated. Tumor stage and survival were studied according to SES group for patients diagnosed with breast cancer between 1998 and 2006, whether screen-detected, interval carcinoma or not attended screening at all. Attendance rates were rather high: 79, 85 and 87% in women with low, intermediate and high SES (p < 0.001), respectively. Compared to the low SES group, odds ratios for attendance were 1.5 (95%CI:1.5-1.6) for the intermediate SES group and 1.8 (95%CI:1.7-1.8) for the high SES group. Moreover, women with low SES had an unfavorable tumor-node-metastasis stage compared to those with high SES. This was seen in non-attendees, among women with interval cancers and with screen-detected cancers. Among non-attendees and interval cancers, the socioeconomic survival disparities were largely explained by stage distribution (48 and 35%) and to a lesser degree by therapy (16 and 16%). Comorbidity explained most survival inequalities among screen-detected patients (23%). Despite the absence of financial barriers for participation in the Dutch mass-screening program, socioeconomic inequalities in attendance rates exist, and women with low SES had a significantly worse tumor stage and lower survival rate.
本研究旨在探讨荷兰的社会经济地位(SES)与参与乳腺癌筛查计划的关联,以及这些因素对疾病分期和预后的影响。荷兰并不存在参与筛查或使用医疗保健的经济障碍。1998 年至 2005 年期间,向埃因霍温癌症登记处覆盖区域内的 50-75 岁女性发送了 1067952 份两年一次的乳房 X 光检查邀请。根据 SES 计算了筛查参与率。对于 1998 年至 2006 年期间被诊断患有乳腺癌的患者,根据 SES 组研究了肿瘤分期和生存情况,这些患者包括筛查发现的肿瘤、间期癌或根本未参加筛查的患者。参与率相当高:SES 较低、中、高的女性分别为 79%、85%和 87%(p<0.001)。与 SES 较低的女性相比,SES 中等组的参与率比值比为 1.5(95%CI:1.5-1.6),SES 较高组为 1.8(95%CI:1.7-1.8)。此外,SES 较低的女性与 SES 较高的女性相比,肿瘤淋巴结转移分期较差。这种情况在未参与者、间期癌患者和筛查发现的癌症患者中均可见。在未参与者和间期癌患者中,社会经济生存差异在很大程度上可以通过分期分布(48%和 35%)来解释,而在一定程度上可以通过治疗(16%和 16%)来解释。在筛查发现的患者中,合并症解释了大部分生存不平等(23%)。尽管荷兰大规模筛查计划不存在参与的经济障碍,但仍存在 SES 参与率的不平等,SES 较低的女性肿瘤分期明显较差,生存率较低。